DK38289A - Fremgangsmaade til selektiv haemning af hiv - Google Patents

Fremgangsmaade til selektiv haemning af hiv

Info

Publication number
DK38289A
DK38289A DK038289A DK38289A DK38289A DK 38289 A DK38289 A DK 38289A DK 038289 A DK038289 A DK 038289A DK 38289 A DK38289 A DK 38289A DK 38289 A DK38289 A DK 38289A
Authority
DK
Denmark
Prior art keywords
hiv
procedure
selective inhibition
inhibition
selective
Prior art date
Application number
DK038289A
Other languages
Danish (da)
English (en)
Other versions
DK38289D0 (da
Inventor
Jeffrey D Lifson
Michael S Mcgrath
Hin-Wing Yeung
Kou Hwang
Original Assignee
Genelabs Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/056,558 external-priority patent/US4795739A/en
Application filed by Genelabs Inc, Univ California filed Critical Genelabs Inc
Publication of DK38289D0 publication Critical patent/DK38289D0/da
Publication of DK38289A publication Critical patent/DK38289A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
DK038289A 1987-05-29 1989-01-27 Fremgangsmaade til selektiv haemning af hiv DK38289A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/056,558 US4795739A (en) 1987-05-29 1987-05-29 Method of inhibiting HIV
US07/179,274 US4869903A (en) 1987-05-29 1988-04-08 Method of selectively inhibiting HIV
PCT/US1988/001794 WO1988009123A1 (fr) 1987-05-29 1988-05-27 Procede d'inhibition selective d'hiv

Publications (2)

Publication Number Publication Date
DK38289D0 DK38289D0 (da) 1989-01-27
DK38289A true DK38289A (da) 1989-03-29

Family

ID=26735430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK038289A DK38289A (da) 1987-05-29 1989-01-27 Fremgangsmaade til selektiv haemning af hiv

Country Status (9)

Country Link
US (1) US4869903A (fr)
EP (1) EP0318562B1 (fr)
JP (1) JPH02500437A (fr)
KR (1) KR960007695B1 (fr)
AU (1) AU613382B2 (fr)
DE (1) DE3886710T2 (fr)
DK (1) DK38289A (fr)
OA (1) OA09030A (fr)
WO (1) WO1988009123A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229216B (it) * 1989-03-31 1991-07-25 Italfarmaco Spa Proteine inibenti i ribosomi e loro derivati.
US5166056A (en) * 1989-04-04 1992-11-24 Genelabs Incorporated Recombinant trichosanthin and coding sequence
AU641388B2 (en) * 1989-04-04 1993-09-23 Genelabs Technologies, Inc. Recombinant trichosanthin and coding sequence
US5101025A (en) * 1989-04-04 1992-03-31 Genelabs Incorporated Recombinant trichosanthin and coding sequence
US5128460A (en) * 1989-04-04 1992-07-07 Genelabs Incorporated Recombinant trichosanthin and coding sequence
WO1990011767A1 (fr) * 1989-04-04 1990-10-18 Genelabs Incorporated Trichosanthine purifiee et procede de preparation
US5248606A (en) * 1990-06-11 1993-09-28 Dowelanco Dna encoding inactive precursor and active forms of maize ribosome inactivating protein
US5635384A (en) * 1990-06-11 1997-06-03 Dowelanco Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
US5178865A (en) * 1990-06-19 1993-01-12 Cedars-Sinai Medical Center Chinese herbal extracts in the treatment of hiv related disease in vitro
US5141923A (en) * 1990-12-31 1992-08-25 Immunology, Inc., A California Corporation Methods for the treatment of retroviral infections
EP0580782B1 (fr) * 1991-04-15 1997-10-08 New York University Proteine anti-vih, tap 29, obtenue a partir de trichosanthes, codage adn et utilisations therapeutiques
WO1993002360A1 (fr) * 1991-07-16 1993-02-04 Transmed Biotech Incorporated Procedes et compositions d'analyse simultanee d'analytes multiples
US6407068B1 (en) 1992-11-05 2002-06-18 Lagrone Robert P. Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells
US5981493A (en) * 1992-11-05 1999-11-09 Lagrone; Robert P. Method of treating humans infected with human immunodeficiency virus
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5639600A (en) * 1994-08-05 1997-06-17 The Regents Of The University Of California Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement
US5580715A (en) * 1994-08-05 1996-12-03 The Regents Of The University Of California Diagnosis of cancer having clonal macrophage involvement
DE19649096A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Glycosidasen
WO1998049311A2 (fr) * 1997-04-30 1998-11-05 De Novo Enzyme Corporation Variantes de toxines de type ricin destinees au traitement d'infections cancereuses, virales ou parasitaires
US7247715B2 (en) * 1997-04-30 2007-07-24 Twinstrand Therapeutics Inc. Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
CN1056383C (zh) * 1997-11-29 2000-09-13 中国科学院昆明动物研究所 栝楼蛋白，其制备方法和在制药中的应用
IL137919A0 (en) * 1998-02-17 2001-10-31 Medarex Inc Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
US6531125B1 (en) 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins
AU7636800A (en) * 1999-10-04 2001-05-10 Twinstrand Therapeutics Inc. Improved ricin-like toxins for treatment of cancer
KR100552964B1 (ko) 2003-08-28 2006-02-15 삼성에스디아이 주식회사 평판표시소자용 도너필름 및 그를 이용한유기전계발광소자의 제조방법
EP3187585A1 (fr) 2010-03-25 2017-07-05 Oregon Health&Science University Glycoprotéines de cytomégalovirus (cmv) et vecteurs de recombinaison
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
EP2568289A3 (fr) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunosélection du virus de la stomatite vésiculaire recombinant exprimant les protéines du VIH-1 par des anticorps largement neutralisants
EP2586461A1 (fr) 2011-10-27 2013-05-01 Christopher L. Parks Particules virales dérivées d'un virus enveloppé
EP2679596B1 (fr) 2012-06-27 2017-04-12 International Aids Vaccine Initiative Variante de la protéine env du VIH-1
EP2848937A1 (fr) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Procédés d'identification de nouveaux immunogènes du VIH-1
EP2873423B1 (fr) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Trimères de glycoprotéines d'enveloppe du vih -1 soluble
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (fr) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Trimères de glycoprotéines de l'enveloppe du vih-1 soluble

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3104208A (en) * 1963-09-17 Restkictocin
US3104204A (en) * 1960-07-11 1963-09-17 Michigan State Alpha sarcin
US3230153A (en) * 1963-06-26 1966-01-18 Birger H Olson Process for the production of regulin by aspergillus restrictus and resulting product
US3842062A (en) * 1972-09-27 1974-10-15 Du Pont Water-soluble complexes of protein and anionic polyelectrolytes such as sodium carboxymethyl cellulose

Also Published As

Publication number Publication date
DE3886710T2 (de) 1994-04-28
EP0318562A1 (fr) 1989-06-07
WO1988009123A1 (fr) 1988-12-01
DE3886710D1 (de) 1994-02-10
AU1952288A (en) 1988-12-21
KR960007695B1 (ko) 1996-06-08
AU613382B2 (en) 1991-08-01
EP0318562B1 (fr) 1993-12-29
JPH02500437A (ja) 1990-02-15
DK38289D0 (da) 1989-01-27
KR890701022A (ko) 1989-12-19
US4869903A (en) 1989-09-26
EP0318562A4 (fr) 1990-03-21
OA09030A (en) 1991-03-31

Similar Documents

Publication Publication Date Title
DK38289A (da) Fremgangsmaade til selektiv haemning af hiv
DK513988A (da) Fremgangsmaade til rensning af roeggas
DK238988D0 (da) Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner
DK404187D0 (da) Fremgangsmaade til fremstilling af thiazolderivater
DK615988A (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK653387D0 (da) Fremgangsmaade til dekomponering af acrylamid
DK653487D0 (da) Fremgangsmaade til dekomponering af acrylamid
DK271588D0 (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK537687A (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
DK298187D0 (da) Applikator til behandling af laeber
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK78388A (da) Fremgangsmaade til fremstilling af 4-acetoxy-3-hydroxyethyl-azetidinon
DK509587D0 (da) Fremgangsmaade til inhibering af genekspression
DK258886A (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK130992A (da) Fremgangsmaade til fremstilling af angiotenxinomdannende enzyminhibitorer
DK504988A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK505888A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK509986A (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK291785A (da) Fremgangsmaade til fremstilling af iminderivater
DK646188D0 (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK64085A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK504888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK98792D0 (da) Fremgangsmaade til fremstilling af oxetanoner
DK256786D0 (da) Fremgangsmaade til fremstilling af triazolderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment